Oncology Institute Inc reports results for the quarter ended June 30 - Earnings Summary

• Oncology Institute Inc TOI.OQ reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -17 cents. The lone analyst forecast for the quarter was for a loss of 13 cents per share.

• Revenue rose 21.5% to $119.80 million from a year ago; analysts expected $114.60 million.

• Oncology Institute Inc's reported EPS for the quarter was a loss of 15 cents​.

• The company reported a quarterly loss of $13.99 million.

• Oncology Institute Inc shares had risen by 100.5% this quarter and gained 1,230.1% so far this year.

FORECAST CHANGES

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

• Wall Street's median 12-month price target for Oncology Institute Inc is $7.00, about 41.3% above its last closing price of $4.11

This summary was machine generated from LSEG data August 13 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)